BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 9150366)

  • 1. A region of interstitial 17q25 allelic loss in ovarian tumors coincides with a defined region of loss in breast tumors.
    Kalikin LM; Frank TS; Svoboda-Newman SM; Wetzel JC; Cooney KA; Petty EM
    Oncogene; 1997 Apr; 14(16):1991-4. PubMed ID: 9150366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detailed deletion analysis of sporadic breast tumors defines an interstitial region of allelic loss on 17q25.
    Kalikin LM; Qu X; Frank TS; Caduff RF; Svoboda SM; Law DJ; Petty EM
    Genes Chromosomes Cancer; 1996 Sep; 17(1):64-8. PubMed ID: 8889509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detailed deletion mapping of chromosome 17q in ovarian and breast cancers: 2-cM region on 17q21.3 often and commonly deleted in tumors.
    Saito H; Inazawa J; Saito S; Kasumi F; Koi S; Sagae S; Kudo R; Saito J; Noda K; Nakamura Y
    Cancer Res; 1993 Jul; 53(14):3382-5. PubMed ID: 8100738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allelotyping defines minimal imbalance at chromosomal region 17q25 in non-serous epithelial ovarian cancers.
    Dion F; Mes-Masson AM; Seymour RJ; Provencher D; Tonin PN
    Oncogene; 2000 Mar; 19(11):1466-72. PubMed ID: 10723138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A deletion unit on chromosome 17q in epithelial ovarian tumors distal to the familial breast/ovarian cancer locus.
    Jacobs IJ; Smith SA; Wiseman RW; Futreal PA; Harrington T; Osborne RJ; Leech V; Molyneux A; Berchuck A; Ponder BA
    Cancer Res; 1993 Mar; 53(6):1218-21. PubMed ID: 8095178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Localization of a tumor suppressor gene associated with the progression of human breast carcinoma within a 1-cM interval of 8p22-p23.1.
    Yokota T; Yoshimoto M; Akiyama F; Sakamoto G; Kasumi F; Nakamura Y; Emi M
    Cancer; 1999 Jan; 85(2):447-52. PubMed ID: 10023714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 400 kb novel deletion unit centromeric to the BRCA1 gene in sporadic epithelial ovarian cancer.
    Tangir J; Muto MG; Berkowitz RS; Welch WR; Bell DA; Mok SC
    Oncogene; 1996 Feb; 12(4):735-40. PubMed ID: 8632895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detailed genetic and physical mapping of tumor suppressor loci on chromosome 3p in ovarian cancer.
    Fullwood P; Marchini S; Rader JS; Martinez A; Macartney D; Broggini M; Morelli C; Barbanti-Brodano G; Maher ER; Latif F
    Cancer Res; 1999 Sep; 59(18):4662-7. PubMed ID: 10493522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Four regions of allelic imbalance on 17q12-qter associated with high-grade breast tumors.
    Plummer SJ; Paris MJ; Myles J; Tubbs R; Crowe J; Casey G
    Genes Chromosomes Cancer; 1997 Dec; 20(4):354-62. PubMed ID: 9408751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic alteration mapping on chromosome 7 in primary breast cancer.
    Bièche I; Khodja A; Driouch K; Lidereau R
    Clin Cancer Res; 1997 Jun; 3(6):1009-16. PubMed ID: 9815778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Marked allelic imbalance on chromosome 5q31 does not explain alpha-catenin expression in epithelial ovarian cancer.
    Tuhkanen H; Anttila M; Kosma VM; Puolakka J; Juhola M; Heinonen S; Mannermaa A
    Gynecol Oncol; 2004 Aug; 94(2):416-21. PubMed ID: 15297182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deletion mapping of two potential chromosome 14 tumor suppressor gene loci in ovarian carcinoma.
    Bandera CA; Takahashi H; Behbakht K; Liu PC; LiVolsi VA; Benjamin I; Morgan MA; King SA; Rubin SC; Boyd J
    Cancer Res; 1997 Feb; 57(3):513-5. PubMed ID: 9012483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of heterozygosity and transcriptome analyses of a 1.2 Mb candidate ovarian cancer tumor suppressor locus region at 17q25.1-q25.2.
    Presneau N; Dewar K; Forgetta V; Provencher D; Mes-Masson AM; Tonin PN
    Mol Carcinog; 2005 Jul; 43(3):141-54. PubMed ID: 15937959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel 4 cM minimal deletion unit on chromosome 6q25.1-q25.2 associated with high grade invasive epithelial ovarian carcinomas.
    Colitti CV; Rodabaugh KJ; Welch WR; Berkowitz RS; Mok SC
    Oncogene; 1998 Jan; 16(4):555-9. PubMed ID: 9484846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A region of allelic imbalance in 1q31-32 in primary breast cancer coincides with a recombination hot spot.
    Benítez J; Osorio A; Barroso A; Arranz E; Díaz-Guillén MA; Robledo M; Rodríguez de Córdoba S; Heine-Suñer D
    Cancer Res; 1997 Oct; 57(19):4217-20. PubMed ID: 9331079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allelic imbalance and microsatellite instability in BRCA1 associated breast and ovarian tumors.
    van der Looij M; Papp J; Sztán M; Pulay T; Elfadil I; Besznyak I; Tóth J; Devilee P; Oláh E
    Int J Oncol; 2001 Apr; 18(4):775-80. PubMed ID: 11251173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A widely expressed transcription factor with multiple DNA sequence specificity, CTCF, is localized at chromosome segment 16q22.1 within one of the smallest regions of overlap for common deletions in breast and prostate cancers.
    Filippova GN; Lindblom A; Meincke LJ; Klenova EM; Neiman PE; Collins SJ; Doggett NA; Lobanenkov VV
    Genes Chromosomes Cancer; 1998 May; 22(1):26-36. PubMed ID: 9591631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Localization of an ovarian cancer tumor suppressor gene to a 0.5-cM region between D22S284 and CYP2D, on chromosome 22q.
    Bryan EJ; Watson RH; Davis M; Hitchcock A; Foulkes WD; Campbell IG
    Cancer Res; 1996 Feb; 56(4):719-21. PubMed ID: 8631002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple regions of chromosome 4 demonstrating allelic losses in breast carcinomas.
    Shivapurkar N; Sood S; Wistuba II; Virmani AK; Maitra A; Milchgrub S; Minna JD; Gazdar AF
    Cancer Res; 1999 Aug; 59(15):3576-80. PubMed ID: 10446964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An 800-kb region of deletion at 13q14 in human prostate and other carcinomas.
    Chen C; Frierson HF; Haggerty PF; Theodorescu D; Gregory CW; Dong JT
    Genomics; 2001 Oct; 77(3):135-44. PubMed ID: 11597138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.